214 related articles for article (PubMed ID: 37211296)
1. Plum-blossom needle tapping enhances the efficacy of ALA photodynamic therapy for facial actinic keratosis in Chinese population: a randomized, multicenter, prospective, and observer-blind study.
Wang P; Xie F; Zhang L; Zhao S; Zhu L; Shen S; Li D; Chen Z; Xiao R; Lu Y; Lei X; Li Y; Zhang G; Zeng W; Wang X
Photodiagnosis Photodyn Ther; 2023 Jun; 42():103611. PubMed ID: 37211296
[TBL] [Abstract][Full Text] [Related]
2. Plum-blossom needling promoted PpIX fluorescence intensity from 5-aminolevulinic acid in porcine skin model and patients with actnic keratosis.
Chen J; Zhang Y; Wang P; Wang B; Zhang G; Wang X
Photodiagnosis Photodyn Ther; 2016 Sep; 15():182-90. PubMed ID: 27375183
[TBL] [Abstract][Full Text] [Related]
3. Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a multicentre, randomized, observer-blind phase III study in comparison with a registered methyl-5-aminolaevulinate cream and placebo.
Dirschka T; Radny P; Dominicus R; Mensing H; Brüning H; Jenne L; Karl L; Sebastian M; Oster-Schmidt C; Klövekorn W; Reinhold U; Tanner M; Gröne D; Deichmann M; Simon M; Hübinger F; Hofbauer G; Krähn-Senftleben G; Borrosch F; Reich K; Berking C; Wolf P; Lehmann P; Moers-Carpi M; Hönigsmann H; Wernicke-Panten K; Helwig C; Foguet M; Schmitz B; Lübbert H; Szeimies RM;
Br J Dermatol; 2012 Jan; 166(1):137-46. PubMed ID: 21910711
[TBL] [Abstract][Full Text] [Related]
4. Modified painless photodynamic therapy for facial multiple actinic keratosis in China: A prospective split-face control study.
Li J; Zhang Y; Zhang G; Zhang L; Zhou Z; Wang P; Wang X
Lasers Surg Med; 2023 Dec; 55(10):871-879. PubMed ID: 37814511
[TBL] [Abstract][Full Text] [Related]
5. Comparison of efficacy, adverse effects and costs between 20 % ALA-PDT and 10 % ALA-PDT for the treatment of actinic keratosis in Chinese patients.
Zhang G; Cao Z; Wang P; Zhu L; Zhang L; Zho Z; Shi L; Wang X
Photodiagnosis Photodyn Ther; 2020 Sep; 31():101605. PubMed ID: 31786334
[TBL] [Abstract][Full Text] [Related]
6. Photodynamic therapy using aminolaevulinic acid for patients with nonhyperkeratotic actinic keratoses of the face and scalp: phase IV multicentre clinical trial with 12-month follow up.
Tschen EH; Wong DS; Pariser DM; Dunlap FE; Houlihan A; Ferdon MB;
Br J Dermatol; 2006 Dec; 155(6):1262-9. PubMed ID: 17107399
[TBL] [Abstract][Full Text] [Related]
7. Home- vs clinic-based daylight photodynamic therapy with 5-aminolevulinic acid nanoemulsion (BF-200 ALA) for actinic keratosis: A randomized, single-blind, prospective study.
Saenz-Guirado S; Ayen-Rodriguez A; Galvez-Moreno M; Velasco-Amador JP; Llamas-Molina JM; Ruiz-Villaverde R; Molina-Leyva A
Photodiagnosis Photodyn Ther; 2024 Apr; 46():104031. PubMed ID: 38438001
[TBL] [Abstract][Full Text] [Related]
8. A multicenter, randomized, vehicle-controlled phase 2 study of blue light photodynamic therapy with aminolevulinic acid HCl 20% topical solution for the treatment of actinic keratoses on the upper extremities: the effect of occlusion during the drug incubation period.
Schmieder GJ; Huang EY; Jarratt M
J Drugs Dermatol; 2012 Dec; 11(12):1483-9. PubMed ID: 23377520
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic and fluorescence evaluation of 20% 5-aminolevulinic acid-mediated photodynamic therapy in actinic keratosis.
Li L; Li Y; Dong H; Yan J; Zhang Y; Zhang C; Xu X
Photodiagnosis Photodyn Ther; 2024 Jun; 47():104100. PubMed ID: 38663488
[TBL] [Abstract][Full Text] [Related]
10. A randomized, double-blind, phase III, multicentre study to evaluate the safety and efficacy of BF-200 ALA (Ameluz(®) ) vs. placebo in the field-directed treatment of mild-to-moderate actinic keratosis with photodynamic therapy (PDT) when using the BF-RhodoLED(®) lamp.
Reinhold U; Dirschka T; Ostendorf R; Aschoff R; Berking C; Philipp-Dormston WG; Hahn S; Lau K; Jäger A; Schmitz B; Lübbert H; Szeimies RM
Br J Dermatol; 2016 Oct; 175(4):696-705. PubMed ID: 26921093
[TBL] [Abstract][Full Text] [Related]
11. Effect of retinoid pretreatment on outcomes of patients treated by photodynamic therapy for actinic keratosis of the hand and forearm.
Galitzer BI
J Drugs Dermatol; 2011 Oct; 10(10):1124-32. PubMed ID: 21968662
[TBL] [Abstract][Full Text] [Related]
12. A randomized, intraindividual, non-inferiority, Phase III study comparing daylight photodynamic therapy with BF-200 ALA gel and MAL cream for the treatment of actinic keratosis.
Dirschka T; Ekanayake-Bohlig S; Dominicus R; Aschoff R; Herrera-Ceballos E; Botella-Estrada R; Hunfeld A; Kremser M; Schmitz B; Lübbert H; Puig S
J Eur Acad Dermatol Venereol; 2019 Feb; 33(2):288-297. PubMed ID: 30022544
[TBL] [Abstract][Full Text] [Related]
13. The impact of occlusive vs non-occlusive application of 5-aminolevulinic acid (BF-200 ALA) on the efficacy and tolerability of photodynamic therapy for actinic keratosis on the scalp and face: A prospective within-patient comparison trial.
Meierhofer C; Silic K; Urban MV; Tanew A; Radakovic S
Photodermatol Photoimmunol Photomed; 2021 Jan; 37(1):56-62. PubMed ID: 32974974
[TBL] [Abstract][Full Text] [Related]
14. Daylight photodynamic therapy with methyl aminolevulinate cream as a convenient, similarly effective, nearly painless alternative to conventional photodynamic therapy in actinic keratosis treatment: a randomized controlled trial.
Rubel DM; Spelman L; Murrell DF; See JA; Hewitt D; Foley P; Bosc C; Kerob D; Kerrouche N; Wulf HC; Shumack S
Br J Dermatol; 2014 Nov; 171(5):1164-71. PubMed ID: 24861492
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of Photodynamic Therapy for Bowen's Disease Using Plum-Blossom Needling to Augment Drug Delivery.
Wu Y; Wang P; Zhang L; Wang B; Wang X
Dermatol Surg; 2018 Dec; 44(12):1516-1524. PubMed ID: 29994952
[TBL] [Abstract][Full Text] [Related]
16. Fractional erbium: YAG laser-assisted photodynamic therapy for facial actinic keratoses: a randomized, comparative, prospective study.
Ko DY; Jeon SY; Kim KH; Song KH
J Eur Acad Dermatol Venereol; 2014 Nov; 28(11):1529-39. PubMed ID: 24341367
[TBL] [Abstract][Full Text] [Related]
17. A Controlled Comparison Study of Topical Fluourouracil 5% Cream Pre-Treatment of Aminolevulinic Acid/Photodynamic Therapy for Actinic Keratosis.
Tanghetti EA; Hamann C; Tanghetti M
J Drugs Dermatol; 2015 Nov; 14(11):1241-4. PubMed ID: 26580872
[TBL] [Abstract][Full Text] [Related]
18. Conventional vs. daylight methyl aminolevulinate photodynamic therapy for actinic keratosis of the face and scalp: an intra-patient, prospective, comparison study in Italy.
Fargnoli MC; Piccioni A; Neri L; Tambone S; Pellegrini C; Peris K
J Eur Acad Dermatol Venereol; 2015 Oct; 29(10):1926-32. PubMed ID: 25809617
[TBL] [Abstract][Full Text] [Related]
19. Intraindividual, right-left comparison of topical 5-aminolevulinic acid photodynamic therapy vs. 5% imiquimod cream for actinic keratoses on the upper extremities.
Sotiriou E; Apalla Z; Maliamani F; Zaparas N; Panagiotidou D; Ioannides D
J Eur Acad Dermatol Venereol; 2009 Sep; 23(9):1061-5. PubMed ID: 19470041
[TBL] [Abstract][Full Text] [Related]
20. Photodynamic therapy for facial actinic keratosis: a clinical and histological study in Chinese patients.
Cai H; Wang YX; Sun P; Yang ZY; Tian R; Liu XY; Li Q; Qiao L; Liu W
Photodiagnosis Photodyn Ther; 2013 Sep; 10(3):260-5. PubMed ID: 23993852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
